Active substance (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Technical information
Presentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
eNrNWF1v2jAUfedXRHl3QigtbApUG2s3pFZltGjTXpBJboqZsVN/AO2vn0PoRqdEbU0t9QWJ2Dn32vf43BPHp5sl9VYgJOGs50dB0/eAJTwl7LbnT27OUdc/7TfiBV7hvWmdoBlELd9LKJay5xejwQwwk8HPy4svYN4H4fcbXsxnC0jUk3laERp8w3J+ifNijhevOEm9Jag5T3t+rtX2qRdLJUwW/TUXv2WOE4jD3ZP90cW0vf88DguwF6BqCeICs9tKUGBWmIkWApgaYAW3XNxXQmfJtNXtnDSbXasQRI5Bci0SGGE1Hwm+Iimk1ZEwlWAVJFun1yBWFFQRpBI8XCRLaQWOF3gzhrthddKfzOhAbRRqosjsUrdz1GlHrY7dZom9raomj1lEmE+PoqjVPolCYGGOH4ARgQzfKFF4AxSlhtZIM0AZF0tNsTJHAKWAGGY8x0KRRFOQiBIwvxhRhOlMLwkDywKPuFCYOiotkYOnJHUUR8DdsxRKicwpvg8WMrfdKiywGQZhpMTdQooV3AjDAlP7//GZpjR8ZdaTnfQ4yrhQtgHXTNUo0PnYdiMGnCnY1FfUTjTVZsdFAvLtYB84q24YIz2jJLHVRaNcGqSajIf1svjuFOUzljAR7iTlB2EpX8u3l6p9ajjKPt+qbSVoLtJo2vrQPYmOj61P4i/Dw5ped6YFzyE0IkbkIdo0ZBk/VJUMtauhHon9vji9dW88wRRq/BuyVDlD5ke76ey4uDuK5UAl6NezG1uOfdcg7q+3fyuhSdr7yw67FuCirxhG1yb++vNRysQLnH27e9Syo7SoVqG5Urn8GIbr9TqYY4kkNpsVZOJ9tpo9i+Du48SJDyl9WSnXjlKflX34dWW2PbXPOZVD3ffu/Z3Lr4yhhIYDalEKvDMZHp69vbL/s97O0h49USJ3YbY2easXrpyXnlXbroN6iakrOxdGIK6yjNTcGdXyMg7L+6p+Iw6Lu6p+4w9GmFHJ
8HcPCzspMfvSC4XF
Listen
